Table 2.
Intestinal disease recurrence for 71 patients with complete follow-up
| Open group (n = 44) | Lap group (n = 27) | P value* | |
|---|---|---|---|
| No intestinal recurrence | 18 (41) | 6 (22) | 0.106 |
| Intestinal recurrence managed at the outpatient department (never readmission) | 10 (23) | 7 (26) | 0.759 |
| Intestinal disease recurrence managed by conservative treatment (never re-resection) | 6 (14) | 8 (30) | 0.1 |
| Medication | 2 | 3 | |
| Combination | 4 | 5 | |
| Med, npo, df | 2 | 4 | |
| Nasogastric tube, npo | 0 | 1 | |
| Med, npo, nasogastric tube | 1 | 0 | |
| Med, npo, nasogastric tube, balloon dilatation | 1 | 0 | |
| Intestinal recurrence requiring re-resection | 10 (23) | 6 (22) | 0.961 |
| Neoterminal ileum and ascending colon | 7 (16) | 6 (22) | |
| Stenosis | 5 | 6 | |
| Fistulizing disease | 2 | 0 | |
| Jejunum | 1 (2) | 0 (0) | |
| Stenosis | 1 | 0 | |
| Fistulizing disease | 0 | 0 | |
| Sigmoid | 2 (5) | 0 (0) | |
| Stenosis | 1 | 0 | |
| Fistulizing disease | 1 | 0 |
Lap = laparoscopic-assisted; med = medication prescribed; npo = nihil per os; df = drip feed.
Data are numbers with percentages in parentheses unless othewise indicated.
*Chi-squared test or Fisher’s exact test.